ATE412010T1 - Selektive peptidische agonisten des vpac2- rezeptors - Google Patents

Selektive peptidische agonisten des vpac2- rezeptors

Info

Publication number
ATE412010T1
ATE412010T1 AT05755072T AT05755072T ATE412010T1 AT E412010 T1 ATE412010 T1 AT E412010T1 AT 05755072 T AT05755072 T AT 05755072T AT 05755072 T AT05755072 T AT 05755072T AT E412010 T1 ATE412010 T1 AT E412010T1
Authority
AT
Austria
Prior art keywords
vpac2 receptor
peptidic agonists
selective peptidic
selective
agonists
Prior art date
Application number
AT05755072T
Other languages
English (en)
Inventor
Bengt Bokvist
Robert Cummins
Wolfgang Glaesner
Jesper Gromada
John Mayer
Lianshan Zhang
Jorge Alsina-Fernandez
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE412010T1 publication Critical patent/ATE412010T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AT05755072T 2004-05-21 2005-05-19 Selektive peptidische agonisten des vpac2- rezeptors ATE412010T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57373904P 2004-05-21 2004-05-21
US62788004P 2004-11-12 2004-11-12
US65660105P 2005-02-25 2005-02-25

Publications (1)

Publication Number Publication Date
ATE412010T1 true ATE412010T1 (de) 2008-11-15

Family

ID=35044731

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05755072T ATE412010T1 (de) 2004-05-21 2005-05-19 Selektive peptidische agonisten des vpac2- rezeptors

Country Status (6)

Country Link
US (1) US20080026996A1 (de)
EP (1) EP1756156B1 (de)
AT (1) ATE412010T1 (de)
CA (1) CA2564740A1 (de)
DE (1) DE602005010578D1 (de)
WO (1) WO2005113594A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1804820A4 (de) 2004-10-08 2009-12-02 Transition Therapeutics Inc Vasoaktive intestinale polypeptid-pharmazeutika
US7595294B2 (en) 2004-10-08 2009-09-29 Transition Therapeutics, Inc. Vasoactive intestinal polypeptide pharmaceuticals
US20090170775A1 (en) * 2004-10-08 2009-07-02 Transition Therapeutics, Inc. Vasoactive intestinal polypeptide compositions
EP1896048A4 (de) * 2005-05-06 2010-11-03 Bayer Pharmaceuticals Corp Pacap (pituitary adenylate cyclase activating peptide)-rezeptor (vpac2)-agonisten und ihre pharmakologischen anwendungsverfahren
JP2009519212A (ja) * 2005-10-26 2009-05-14 イーライ リリー アンド カンパニー 選択的ｖｐａｃ２受容体ペプチドアゴニスト
WO2007101146A2 (en) * 2006-02-28 2007-09-07 Eli Lilly And Company Selective vpac2 receptor peptide agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242563B1 (en) * 1998-07-20 2001-06-05 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Peptide analogues
CA2379604A1 (en) * 1999-09-28 2001-04-05 Bayer Corporation Pituitary adenylate cyclase activating peptide (pacap) receptor 3 (r3) agonists and their pharmacological methods of use
BR0312621A (pt) * 2002-07-12 2005-12-06 Bayer Pharmaceuticals Corp Agonistas de receptor (vpac2) de peptìdeo de ativação de pituitária adenilato ciclase (pacap)

Also Published As

Publication number Publication date
EP1756156B1 (de) 2008-10-22
DE602005010578D1 (de) 2008-12-04
EP1756156A1 (de) 2007-02-28
WO2005113594A1 (en) 2005-12-01
US20080026996A1 (en) 2008-01-31
CA2564740A1 (en) 2005-12-01

Similar Documents

Publication Publication Date Title
NO20082345L (no) Selektive VPAC2 reseptorpeptidagonister
ATE529442T1 (de) Verbesserte humane interferon-moleküle und ihre verwendungen
WO2006097536A3 (en) Dimeric peptide agonists of the glp-1 receptor
GB2436266A (en) Modified human growth hormone
GB2430677A8 (en) Novel antigenbinding polypeptides and their uses
EA200600055A1 (ru) Агонисты рецептора меланокортина 4 (мк4 ) и их применение
MXPA06011924A (es) Dispositivo de liberacion continua base polimeros.
EA200701918A1 (ru) Белок липокалин
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
WO2007101146A3 (en) Selective vpac2 receptor peptide agonists
WO2007133828A3 (en) Selective vpac2 receptor peptide agonists
MXPA06003474A (es) Agonistas de receptores de melanocortina.
CY1110980T1 (el) Εμβολιο συνδυασμων πεπτιδιων εναντια στην αλλεργια απο γατες
ATE546463T1 (de) Modifizierte humane wachstumshormon-polypeptide und ihre verwendungen
UY29357A1 (es) Agonistas de pyy y sus usos
DK2068909T3 (da) Modificerede FGF-21-polypeptider og anvendelse heraf
MX2007002675A (es) Antagonistas anti-beta7 humanizados y usos para los mismos.
ATE389670T1 (de) Selektive peptidische agonisten des vpac2- rezeptors
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
WO2006023356A3 (en) Selective vpac2 receptor peptide agonists
SG10201803541TA (en) Biologically active c-terminal arginine-containing peptides
ATE412010T1 (de) Selektive peptidische agonisten des vpac2- rezeptors
EA200702193A1 (ru) Гликозилирование белков
ATE542535T1 (de) Verwendung von azapaullonen zur vorbeugung und behandlung pankreatischer autoimmunkrankheiten
CY1109803T1 (el) Φαρμακευτικες συνθεσεις που βασιζονται σε ανταγωνιστες νκ2 για παιδιατρικη χρηση

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties